Peter H. Seeberger

Peter H. Seeberger serves as Director at the Max Planck Institute for Colloids and Interfaces in Potsdam, Germany, where he leads pioneering research at the intersection of chemistry and medical science.

As a leading figure in glycosciences, Seeberger's research focuses on the synthesis and application of sugar molecules. His groundbreaking work centers on developing rapid and reliable methods for producing synthetic sugars, which has opened new pathways in medical research. These synthetic sugars serve as crucial components in novel vaccines targeting infectious diseases, particularly those caused by multi-resistant hospital pathogens. His contributions have fundamentally advanced the understanding of carbohydrate chemistry and its practical applications in combating challenging medical conditions.

• Pioneering research in glycosciences and sugar molecule applications
• Development of innovative methods for synthetic sugar production
• Application of carbohydrate chemistry to vaccine development
• Research on sugars as components in vaccines against resistant pathogens

Seeberger received the prestigious Stifterverband Science Prize in 2017, awarded in collaboration with the Max Planck Society. This recognition highlighted his significant contributions to science, particularly his work translating fundamental carbohydrate research into practical medical applications that address critical public health challenges.